Article
Predicting prognosis in colorectal cancer patients with curative resection using albumin, lymphocyte count and RAS mutations.
Scientific reports - 23 Jun 2024
Miyata Toshiya, Hayama Tamuro, Ozawa Tsuyoshi, Nozawa Keijiro, Misawa Takeyuki, Fukagawa Takeo
Abstract excerpt
Colorectal cancer (CRC) poses a significant global health challenge, demanding reliable prognostic tools to guide treatment decisions. This study introduces a novel prognostic scoring system, the albumin-total lymphocyte count-RAS index (ALRI), integrating serum albumin, lymphocyte count, and RAS gene mutations. A cohort of 445 stage I-III CRC patients undergoing curative resection was analyzed, revealing ALRI's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
